Terms: = Germ cell tumor AND FANCC, ENSG00000158169, 2176, RP11-80I15_2, FAC, FA3, FACC, FLJ14675 AND Prognosis
10178 results:
1. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
[TBL] [Abstract] [Full Text] [Related]
2. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
Stoyukhina AS
Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
[TBL] [Abstract] [Full Text] [Related]
3. Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy.
Halpert MM; Burns BA; Rosario SR; Withers HG; Trivedi AJ; Hofferek CJ; Gephart BD; Wang H; Vazquez-Perez J; Amanya SB; Hyslop ST; Yang J; Kemnade JO; Sandulache VC; Konduri V; Decker WK
FASEB J; 2024 May; 38(10):e23644. PubMed ID: 38738472
[TBL] [Abstract] [Full Text] [Related]
4. The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma.
Yu X; Lai M; Li J; Wang L; Ye K; Zhang D; Hu Q; Li S; Hu X; Wang Q; Ma M; Xiao Z; Zhou J; Shi C; Luo L; Cai L
Neurosurg Rev; 2024 May; 47(1):212. PubMed ID: 38727935
[TBL] [Abstract] [Full Text] [Related]
5. Treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
Chang JY; Ruff SM; Cloyd JM
Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
[TBL] [Abstract] [Full Text] [Related]
6. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
7. Toll-like receptors 1-9 in small bowel neuroendocrine tumors-Clinical significance and prognosis.
Hiltunen N; Kemi N; Väyrynen JP; Böhm J; Kauppila JH; Huhta H; Helminen O
PLoS One; 2024; 19(5):e0302813. PubMed ID: 38709790
[TBL] [Abstract] [Full Text] [Related]
8. VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis.
Guo M; Zhang J; Han J; Hu Y; Ni H; Yuan J; Sun Y; Liu M; Gao L; Liao W; Ma C; Liu Y; Li S; Li N
J Transl Med; 2024 May; 22(1):419. PubMed ID: 38702818
[TBL] [Abstract] [Full Text] [Related]
9. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
[TBL] [Abstract] [Full Text] [Related]
10. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
Liu Z; Yu L; Lai J; Zhang R
Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
[TBL] [Abstract] [Full Text] [Related]
11. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
Klabusay M; Bábková B
Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
[TBL] [Abstract] [Full Text] [Related]
12. A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
Huang R; Lu X; Sun X; Wu H
Int J Immunopathol Pharmacol; 2024; 38():3946320241249395. PubMed ID: 38687369
[No Abstract] [Full Text] [Related]
13. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract] [Full Text] [Related]
14. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract] [Full Text] [Related]
15.
Ou Y; Luo H; Zhang Q; Du T; Liu R; Wang D; Chen J; Dong M; Wang Y; Yang Z; Wang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):144. PubMed ID: 38682183
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract] [Full Text] [Related]
17. [SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis].
Hua D; Zhou XX; Wang Q; Sun CY; Shi CJ; Luo WJ; Jiang ZD; Yu SZ
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):430-438. PubMed ID: 38678322
[No Abstract] [Full Text] [Related]
18. HIF-1α-mediated LAMC1 overexpression is an unfavorable predictor of prognosis for glioma patients: evidence from pan-cancer analysis and validation experiments.
Bai J; Zhao Y; Shi K; Fan Y; Ha Y; Chen Y; Luo B; Lu Y; Jie W; Shen Z
J Transl Med; 2024 Apr; 22(1):391. PubMed ID: 38678297
[TBL] [Abstract] [Full Text] [Related]
19. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.
Tomoszková S; Škarda J; Lipina R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674026
[TBL] [Abstract] [Full Text] [Related]
20. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract] [Full Text] [Related]
[Next]